Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination

QR Code

Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination

The use of reamberin and cycloferon combination for increasing the antibacterial therapy efficacy in patients with chronic sepsis (CS) was studied. It was shown that the combination provided more rapid elimination of the CS exacerbation symptoms, normalization of the hematologic indices, bacteriemia...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Frolov, N. A. Peresadin, R. B. Chkhetiany, O. V. Kruglova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	chronic sepsis pathogenesis antibacterial therapy cytokines cycloferon reamberin
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The influence of reamberin on oxygen balance, oxidative stress and lung dysfunction in patients with abdominal sepsis
by: A. B. Tolkach, et al.
Published: (2012-06-01)

Antiulcerous Efficacy of Reamberin at the Background of the Stress Ulcerogenic Factor Action
by: O. P. Rodina, et al.
Published: (2020-05-01)

Metabolic Therapy and Pulmonary Disfunction in Patients with Obstetric Sepsis
by: A. YU. Yakovlev, et al.
Published: (2020-05-01)

The Efficacy of Reamberin in Correction of Lipoperoxidation Processes in the Gastrointestinal Form of Salmonellosis
by: V. F. Pavelkina, et al.
Published: (2020-05-01)

Reamberin in Tuberculosis Chemotherapy and Its Effect on Liver Function
by: I. S. Gelberg, et al.
Published: (2020-05-01)

Cycloferon Efficacy in Viral and Bacterial Diseases of Children (Clinical Review)
by: M. G. Romantsov, et al.
Published: (2020-05-01)

Cycloferon Efficacy of Therapy of Chronic Hepatitis B (Results of Randomized Multicentre Study)
by: T. V. Sologub, et al.
Published: (2020-05-01)

Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
by: L. V. Nowicka-Usenko, et al.
Published: (2016-10-01)

Cycloferon in Complex Therapy of Chronic Brucellosis
by: A. N. Smagina, et al.
Published: (2020-05-01)

Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN")
by: V. B. Vasilyuk, et al.
Published: (2022-12-01)

Clinical Efficacy of Cycloferon in Complex Therapy of Infectious Mononucleosis in Pediatrics
by: E. B. Kasymova, et al.
Published: (2020-05-01)

Cycloferon in Complex Medicamentous Management of Chronic Laryngitis
by: E. V. Demchenko, et al.
Published: (2020-05-01)

Therapeutic Efficacy of Various Formulations of Cycloferon in the Treatment of Infectious Mononucleosis in Children
by: D. YU. Kurmaeva, et al.
Published: (2020-05-01)

Cycloferon in the Treatment of Immunocompromised Patients with Allergic Rhinitis
by: N. S. Tataurshchikova
Published: (2020-05-01)

Cycloferon and Management of Herpes Virus Infection
by: L. M. Alimbarova
Published: (2020-05-01)

Evaluation of Safety and Pharmacotherapeutic Efficacy of Cycloferon in Treatment of Astrakhan Rickettsial Fever
by: YU. V. Sherysheva, et al.
Published: (2020-05-01)

Type 1 and Type 2 Interferon Inductor (Cycloferon) in Therapy of Children with Pyelonephritis Associated with Herpes Viruses
by: S. B. Orekhova, et al.
Published: (2020-05-01)

Experimental and Clinicolaboratory Evaluation of Complex Therapy Efficacy in Arboviral Infections
by: M. G. Romatsov, et al.
Published: (2020-05-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Comparative Efficacy of Clinical Use of Reamberin, Remaxol and Ademethionine in Patients with Tuberculosis of the Respiratory Organs and Liver Drug-Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Cycloferon Efficacy in the Treatment of Acute Respiratory Tract Viral Infection and Influenza During the Morbidity Outbreak in 2009-2010
by: M. G. Pomantsov, et al.
Published: (2020-05-01)

Modern ideas of the role of the immune process and hemostasis in the pathogenesis of sepsis
by: M. V. Osikov, et al.
Published: (2024-12-01)

Cycloferon Therapy of Chronic Gastroduodenitis in Children
by: S. Yu. Yermak, et al.
Published: (2020-05-01)

Cycloferon as an Agents of Antirelpsing Therapy in Patients with Chronic Hyperplastic Sinusitis
by: I. P. Vasilenko, et al.
Published: (2020-05-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

When to start antibiotic therapy in patients with sepsis in the ICU?
by: V. A. Rudnov, et al.
Published: (2020-11-01)

Monitoring of Side Effects and Estimation of Cycloferon Efficacy in Treatment of Children with Frequent and Prolonged Diseases
by: S. A. Lyalikov, et al.
Published: (2020-05-01)

The Influence of Cycloferone on the Effectiveness of Pharmacotherapy of Wide Spectrum of Infectious Diseases in Children and Adults: Systematic Review and Meta-Analysis
by: N. K. Mazina, et al.
Published: (2020-05-01)

Clinicoimmunological Monitoring of Therapy in Patients with Associated Forms of Yersiniosis
by: A. V. Gordeets, et al.
Published: (2020-05-01)

Immunomodulators in Therapy of Respiratory Infections
by: V. A. Isakov, et al.
Published: (2020-05-01)

EFFECT OF CYCLOFERON ON THE RESULTS OF TREATMENT OF PATIENTS WITH CHRONIC EROSIVE GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI AND HERPES INFECTION
by: T. E. AFANASENKOVA, et al.
Published: (2017-06-01)

Immune correction in patients with sepsis (literature review)
by: A. V. Stepanov, et al.
Published: (2024-04-01)

Cycloferon, as an Agent in the Therapy and Urgent Prophylaxis of Influenza and Acute Respiratory Tract Viral Infection (Multicentre Randomized Controlled Comparative Study)
by: T. V. Sologub, et al.
Published: (2020-05-01)

Inflammasomes and Signaling Pathways: Key Mechanisms in the Pathophysiology of Sepsis
by: Jhan S. Saavedra-Torres, et al.
Published: (2025-06-01)

Interferon Inductors in Treatment of Associative Forms of Tick-Borne Infection in Children
by: A. V. Gordeets, et al.
Published: (2020-05-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

The Anti-Inflammatory Potential of Levosimendan in Sepsis: An Experimental Study Using a LPS-Induced Rat Model
by: Elif Dedeler Ertanıdır, et al.
Published: (2025-06-01)

The Overlapping Biology of Sepsis and Cancer and Therapeutic Implications
by: Amit Kumar Tripathi, et al.
Published: (2025-05-01)

Extracorporeal Cytokine Adsorption in Sepsis: Current Evidence and Future Perspectives
by: Matteo Guarino, et al.
Published: (2025-07-01)

INFLUENCE OF CYCLOFERON ON THE CELLULAR SUSCEPTIBILITY TO INTERFERON-α2 IN VITRO IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN– BARR VIRUS
by: L. M. Kurtasova, et al.
Published: (2018-12-01)